Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses (Q90974167)
Jump to navigation
Jump to search
scientific article published on 28 October 2019
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses |
scientific article published on 28 October 2019 |
Statements
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses (English)
Vassiliki A Papadimitrakopoulou
Erminia Massarelli
James W Welsh
Chad Tang
Kenneth R Hess
Taylor R Cushman
Vivek Subbiah
Joe Y Chang
George R Simon
Rishab Ramapriyan
Hampartsoum B Barsoumian
Hari Menon
Maria Angelica Cortez
Quynh Nguyen
Padmanee Sharma
Adi Diab
Vivek Verma
Uma Raju
Sherif G Shaaban
Ramona Dadu
Kelvin Wang
Clark Anderson
Daniel R Gomez
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference